DD140259A5 - Lagerfaehige cholesterinoxidasepraeparation - Google Patents
Lagerfaehige cholesterinoxidasepraeparation Download PDFInfo
- Publication number
- DD140259A5 DD140259A5 DD78109434A DD10943478A DD140259A5 DD 140259 A5 DD140259 A5 DD 140259A5 DD 78109434 A DD78109434 A DD 78109434A DD 10943478 A DD10943478 A DD 10943478A DD 140259 A5 DD140259 A5 DD 140259A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- preparation
- oxidease
- storageable
- cholesterine
- buffer
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 1
- 239000003381 stabilizer Substances 0.000 claims description 8
- 239000000337 buffer salt Substances 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 11
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 11
- 235000011130 ammonium sulphate Nutrition 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 108010089254 Cholesterol oxidase Proteins 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 230000000087 stabilizing effect Effects 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010000659 Choline oxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- -1 quaternary ammonium ions Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2755799A DE2755799B1 (de) | 1977-12-14 | 1977-12-14 | Lagerfaehige Cholesterinoxidasepraeparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD140259A5 true DD140259A5 (de) | 1980-02-20 |
Family
ID=6026143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD78109434A DD140259A5 (de) | 1977-12-14 | 1978-11-30 | Lagerfaehige cholesterinoxidasepraeparation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4366249A (cs) |
| EP (1) | EP0002438B1 (cs) |
| JP (1) | JPS5489015A (cs) |
| AT (1) | AT363893B (cs) |
| CA (1) | CA1108050A (cs) |
| CS (1) | CS215112B2 (cs) |
| DD (1) | DD140259A5 (cs) |
| DE (2) | DE2755799B1 (cs) |
| DK (1) | DK145614C (cs) |
| HU (1) | HU179431B (cs) |
| IL (1) | IL55946A (cs) |
| IT (1) | IT1099545B (cs) |
| ZA (1) | ZA786974B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047327A (en) * | 1982-04-02 | 1991-09-10 | Ivan E. Modrovich | Time-stable liquid cholesterol assay compositions |
| JPS60194373U (ja) * | 1984-06-04 | 1985-12-24 | 株式会社ピ−エフユ− | フエライトコアの実装構造 |
| AU2015202990B2 (en) * | 1999-06-21 | 2017-11-02 | Sekisui Medical Co., Ltd. | Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same |
| AU2008201734B2 (en) * | 1999-06-21 | 2012-07-05 | Sekisui Medical Co., Ltd. | Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same |
| JP4542234B2 (ja) * | 1999-06-21 | 2010-09-08 | 積水メディカル株式会社 | コレステロール定量用試料の前処理方法およびこれを利用する特定のリポ蛋白中のコレステロール定量法 |
| CA2375894C (en) * | 1999-06-21 | 2012-05-22 | Daiichi Pure Chemicals Co., Ltd. | Reaction accelerator-enchanced activity of cholesterol metabolizing enzymes in methods of quantifying cholesterol |
| WO2013161676A1 (ja) * | 2012-04-27 | 2013-10-31 | 協和メデックス株式会社 | コレステロールオキシダーゼの安定化方法 |
| WO2022032178A1 (en) | 2020-08-06 | 2022-02-10 | Mate Precision Technologies Inc. | Vise assembly |
| WO2022032148A1 (en) | 2020-08-06 | 2022-02-10 | Mate Precision Technologies Inc. | Tooling base assembly |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2344567A1 (fr) * | 1976-03-17 | 1977-10-14 | Mitsubishi Chem Ind | Procede de preservation de glucose-isomerase et solution de glucose-isomerase |
| US4077842A (en) * | 1976-03-19 | 1978-03-07 | Cory Robert Paul | Stabilized glucose isomerase enzyme concentrate |
| JPS52143285A (en) * | 1976-05-26 | 1977-11-29 | Kikkoman Corp | Stabilization of cholesterol-oxydase |
-
1977
- 1977-12-14 DE DE2755799A patent/DE2755799B1/de active Granted
-
1978
- 1978-10-03 AT AT0712678A patent/AT363893B/de not_active IP Right Cessation
- 1978-10-04 DE DE7878101065T patent/DE2860583D1/de not_active Expired
- 1978-10-04 EP EP78101065A patent/EP0002438B1/de not_active Expired
- 1978-10-26 IT IT29156/78A patent/IT1099545B/it active
- 1978-11-02 DK DK489278A patent/DK145614C/da not_active IP Right Cessation
- 1978-11-08 CA CA315,983A patent/CA1108050A/en not_active Expired
- 1978-11-14 IL IL55946A patent/IL55946A/xx unknown
- 1978-11-30 DD DD78109434A patent/DD140259A5/de not_active IP Right Cessation
- 1978-12-08 CS CS788159A patent/CS215112B2/cs unknown
- 1978-12-12 JP JP15275878A patent/JPS5489015A/ja active Granted
- 1978-12-13 ZA ZA00786974A patent/ZA786974B/xx unknown
- 1978-12-13 HU HU78BO1754A patent/HU179431B/hu unknown
-
1982
- 1982-01-15 US US06/339,760 patent/US4366249A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IT1099545B (it) | 1985-09-18 |
| IL55946A (en) | 1981-11-30 |
| DE2755799C2 (cs) | 1979-04-12 |
| EP0002438A1 (de) | 1979-06-27 |
| ATA712678A (de) | 1981-02-15 |
| DE2755799B1 (de) | 1978-08-03 |
| US4366249A (en) | 1982-12-28 |
| DE2860583D1 (en) | 1981-04-23 |
| IT7829156A0 (it) | 1978-10-26 |
| ZA786974B (en) | 1979-12-27 |
| EP0002438B1 (de) | 1981-04-01 |
| DK145614C (da) | 1983-06-13 |
| JPS5489015A (en) | 1979-07-14 |
| CS215112B2 (en) | 1982-07-30 |
| CA1108050A (en) | 1981-09-01 |
| HU179431B (en) | 1982-10-28 |
| DK489278A (da) | 1979-06-15 |
| DK145614B (da) | 1982-12-27 |
| AT363893B (de) | 1981-09-10 |
| JPS5724760B2 (cs) | 1982-05-26 |
| IL55946A0 (en) | 1979-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68918847T2 (de) | Stabile pharmazeutische zusammensetzung. | |
| EP0002438B1 (de) | Lagerfähige Cholesterinoxidasepräparation | |
| DE2609039B2 (de) | Verfahren zum Herstellen von beständigem Natriumpercarbonat | |
| DE69521520T2 (de) | Biologisches produkt zur physikalisch-chemischen weinstabilisierung | |
| DE3337566C2 (cs) | ||
| EP0042969B1 (de) | Verfahren zur Stabilisierung der alkalischen Phosphatase | |
| DE1045377B (de) | Verfahren zum Stabilisieren von zur Herstellung von Fungiziden geeignetem Selendisulfid, das durch Zusatz eines hydrophilen kolloidalen Suspensionsmittels aktiviert ist | |
| DE69315059T2 (de) | Enzymatische Zubereitungen die Papain oder Chymotrypsin enthalten zur dauerhafte enzymatische Entfernung von Haaren | |
| DE69807059T2 (de) | Enzym-konzentrat | |
| DE1642083B1 (de) | Jodophores Euterdesinfektionsmittel | |
| DE3234761C2 (cs) | ||
| DE68903937T2 (de) | Waessrige elcatonin-loesung enthaltende arzneizubereitung. | |
| EP1008350A1 (de) | Stabilisiertes Antithrombin III-Präparat | |
| DE2239210C3 (de) | Verfahren zur Herstellung von a- Galactosidase, die eine starke a- Galactosidase-Aktivität und eine äußerst geringe Invertase-Aktivität aufweist, und deren Verwendung zur Zerlegung von Raffinose | |
| DE1131360B (de) | Verfahren zum Stabilisieren von waessrigen Loesungen, die neben Vitamin B noch Vitamin B und Vitamin C enthalten | |
| DE69030798T2 (de) | Stabilisierung des Glucose-Oxidase-Enzyms in flüssigem Reagenz | |
| DE3404876A1 (de) | Verfahren zur verbesserung der selektiven aktivitaetshemmung von humaner pankreas- und speichelamylase sowie eine hierfuer geeignete inhibitorzubereitung | |
| DE283061C (cs) | ||
| DE1517751C3 (de) | Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten | |
| DE2036113B2 (de) | Wäßriges Tetramisolpräparat | |
| DE1642582C3 (de) | Zusatzmittel zur Erhöhung der Lagerfähigkeit von Cftrat-Lyase und Verfahren zur Verbesserung der Lagerfähigkeit von Citrat-Lyase | |
| DE2234412B2 (de) | Verfahren zur Stabilisierung und Fällung konzentrierter Protease-Lösungen | |
| DE2163062C3 (de) | Mittel zum Frischhalten von Schnittblumen | |
| DE4041543C2 (de) | Stabilisierung von Ascorbinsäure in stark saurer Lösung | |
| AT153166B (de) | Verfahren zum Bleichen von Fasern. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |